1. Botulinum Toxin: Does it have a Place in the Management of Depression?

   • Matthew V. Rudorfer

   Editorial 01 March 2018 Pages: 97 - 100

2. Prescribed Dose of Opioids and Overdose: A Systematic Review and Meta-Analysis of Unintentional Prescription Opioid Overdose

   • Adeleke D. Adewumi
   • Samantha A. Hollingworth
   • Rosa Alati

   Systematic Review 01 March 2018 Pages: 101 - 116

   

3. Depression in Multiple Sclerosis: Epidemiology, Aetiology, Diagnosis and Treatment

   • Claudio Solaro
   • Giulia Gamberini
   • Fabio Giuseppe Masuccio

   Review Article 07 February 2018 Pages: 117 - 133

4. Tardive Dyskinesia Associated with Atypical Antipsychotics: Prevalence, Mechanisms and Management Strategies

   • Katharina Stegmayer
   • Sebastian Walther
   • Peter van Harten

   Review Article 09 February 2018 Pages: 135 - 147

   

5. Use of α2δ Ligands for Restless Legs Syndrome/Willis Ekbom Disease

   • Michele A. Faulkner

   Review Article 26 February 2018 Pages: 149 - 159

6. An Update on the Use of Disease-Modifying Therapy in Pregnant Patients with Multiple Sclerosis

   • Caila Vaughn
   • Aisha Bushra
   • Bianca Weinstock-Guttman

   Review Article 05 March 2018 Pages: 161 - 178

   

7. Effect of the Glutamate NMDA Receptor Antagonist Memantine as Adjunctive Treatment in Borderline Personality Disorder: An Exploratory, Randomised, Double-Blind, Placebo-Controlled Trial

   • Jayashri Kulkarni
   • Natalie Thomas
   • Caroline Gurvich

   Original Research Article 16 March 2018 Pages: 179 - 187